RPID

MKT CAP:$104M

Rapid Micro Biosystems, Inc.

Market Cap

$104M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical - Devices·🇺🇸·NASDAQ

Stock Price

$2.38-$0.76 (-24.20%)

Apr 22, 2026

Company Details

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and...

CEO

Robert G. Spignesi Jr.

IPO Date

Jul 15, 2021

Website

www.rapidmicrobio.com

Key Metrics TTM

Revenue

$34M

+19.7% YoY

Net Income

-$47M

EPS (Diluted)

-$1.06

Free Cash Flow

-$31M

Revenue / Share

$0.75

Gross Margin

17.4%

Operating Margin

-141.1%

Net Margin

-140.3%

FCF Margin

-92.4%

P/S

3.1x

P/E

—

Earnings Reports

Q1 2026

May 8, 2026

PENDING

FY 2025

Mar 12, 2026

$34M+19.7%EPS -$1.05

Q4 2025

Mar 12, 2026

$11M+37.3%EPS -$0.28

Q3 2025

Nov 7, 2025

$8M+3.1%EPS -$0.25

Q2 2025

Aug 12, 2025

$7M+9.7%EPS -$0.27

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$4M	-$2M	-$15M
Q2 22	$4M	-$1M	-$14M
Q3 22	$5M	-$3M	-$17M
Q4 22	$4M	-$3M	-$17M
Q1 23	$5M	-$2M	-$15M
Q2 23	$5M	-$2M	-$15M
Q3 23	$6M	-$2M	-$14M
Q4 23	$6M	-$172.0K	-$12M
Q1 24	$6M	-$2M	-$14M
Q2 24	$7M	-$189.0K	-$13M
Q3 24	$8M	$622.0K	-$12M
Q4 24	$8M	$981.0K	-$10M
Q1 25	$7M	$404.0K	-$12M
Q2 25	$7M	$2M	-$12M
Q3 25	$8M	$2M	-$11M
Q4 25	$11M	$1M	-$12M

Valuation

Quarter	P/S	P/E
Q1 22	12.8x	—
Q2 22	6.9x	—
Q3 22	8.1x	—
Q4 22	3.4x	—
Q1 23	3.3x	—
Q2 23	2.2x	—
Q3 23	2.3x	—
Q4 23	1.9x	—
Q1 24	1.8x	—
Q2 24	1.2x	—
Q3 24	1.5x	—
Q4 24	1.4x	—
Q1 25	3.9x	—
Q2 25	5.0x	—
Q3 25	4.8x	—
Q4 25	3.8x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	-$17M	-$19M
Q2 22	-$15M	-$17M
Q3 22	-$15M	-$17M
Q4 22	-$12M	-$12M
Q1 23	-$17M	-$17M
Q2 23	-$9M	-$9M
Q3 23	-$10M	-$10M
Q4 23	-$9M	-$10M
Q1 24	-$16M	-$16M
Q2 24	-$10M	-$11M
Q3 24	-$9M	-$9M
Q4 24	-$10M	-$10M
Q1 25	-$9M	-$9M
Q2 25	-$10M	-$10M
Q3 25	-$9M	-$9M
Q4 25	-$2M	-$2M

Capital Expenditures

Quarter	CapEx
Q1 22	$2M
Q2 22	$2M
Q3 22	$2M
Q4 22	$811.0K
Q1 23	$759.0K
Q2 23	$215.0K
Q3 23	$453.0K
Q4 23	$418.0K
Q1 24	$585.0K
Q2 24	$459.0K
Q3 24	$223.0K
Q4 24	$98.0K
Q1 25	$319.0K
Q2 25	$366.0K
Q3 25	$73.0K
Q4 25	$92.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	-16.7%	+30.5%
Q2 22	-37.0%	+5.5%
Q3 22	-31.3%	+13.7%
Q4 22	-16.0%	+9.5%
Q1 23	+21.0%	+3.9%
Q2 23	+29.6%	+11.8%
Q3 23	+29.7%	-4.8%
Q4 23	+44.9%	-14.4%
Q1 24	+11.4%	-0.1%
Q2 24	+32.3%	-0.3%
Q3 24	+23.7%	-4.6%
Q4 24	+29.7%	-0.4%
Q1 25	+28.4%	-5.1%
Q2 25	+9.7%	-2.9%
Q3 25	+3.1%	-2.2%
Q4 25	+37.3%	+27.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$983.0K	23.6%
Q2 22	$1M	32.6%
Q3 22	$673.0K	14.2%
Q4 22	$1M	25.3%
Q1 23	$1M	24.7%
Q2 23	$1M	24.7%
Q3 23	$1M	20.4%
Q4 23	$1M	16.1%
Q1 24	$1M	19.3%
Q2 24	$1M	17.7%
Q3 24	$929.0K	12.2%
Q4 24	$689.0K	8.4%
Q1 25	$1M	14.5%
Q2 25	$1M	16.8%
Q3 25	$1M	14.6%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 22	$4M	$6M	$3M
Q2 22	$3M	$6M	$3M
Q3 22	$3M	$7M	$4M
Q4 22	$3M	$7M	$4M
Q1 23	$3M	$6M	$3M
Q2 23	$3M	$7M	$3M
Q3 23	$3M	$6M	$3M
Q4 23	$3M	$6M	$3M
Q1 24	$4M	$6M	$3M
Q2 24	$4M	$6M	$4M
Q3 24	$4M	$6M	$3M
Q4 24	$3M	$5M	$3M
Q1 25	$4M	$6M	$3M
Q2 25	$3M	$6M	$3M
Q3 25	$4M	$6M	$3M
Q4 25	$3M	$5M	$3M

Revenue Segments

Quarter	Product and service revenue - non-recurring	Product and service revenue - recurring	Product	Service
Q1 22	$2M	$3M	—	—
Q2 22	$1M	$3M	—	—
Q3 22	—	—	$3M	$2M
Q4 22	—	—	$3M	$2M
Q1 23	—	—	$3M	$2M
Q2 23	—	—	$3M	$2M
Q3 24	—	—	$5M	$2M
Q4 24	—	—	$6M	$3M
Q3 25	—	—	$6M	$3M

Revenue by Geography

Quarter	All other countries	Germany	Switzerland	United states	All Other Countries	United States	Japan
Q1 22	$815.0K	$424.0K	$879.0K	$2M	—	—	—
Q2 22	$531.0K	$401.0K	$609.0K	$2M	—	—	—
Q3 22	—	$1M	$608.0K	—	$627.0K	$2M	—
Q4 22	—	$411.0K	$660.0K	—	$988.0K	$2M	—
Q1 23	—	$413.0K	$973.0K	—	$560.0K	$2M	$1M
Q2 23	—	$501.0K	$960.0K	—	$853.0K	$3M	$68.0K
Q3 23	—	$478.0K	$1M	—	$2M	$3M	$167.0K
Q4 23	—	$724.0K	$1M	—	$777.0K	$3M	$941.0K
Q1 24	—	$464.0K	$972.0K	—	$1M	$2M	$800.0K
Q2 24	—	$970.0K	$2M	—	$1M	$3M	$372.0K
Q3 24	—	$923.0K	$1M	—	$2M	$3M	$227.0K
Q4 24	—	$692.0K	$2M	—	$3M	$2M	$654.0K
Q1 25	—	$1M	$1M	—	$1M	$2M	$1M
Q2 25	—	$2M	$2M	—	$961.0K	$2M	$296.0K
Q3 25	—	$2M	$1M	—	$1M	$3M	$915.0K
Q4 25	—	$875.0K	$2M	—	$2M	$6M	$261.0K

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$63M	$100M	$162M
Q2 22	$50M	$94M	$144M
Q3 22	$26M	$89M	$115M
Q4 22	$27M	$82M	$109M
Q1 23	$24M	$75M	$100M
Q2 23	$29M	$77M	$106M
Q3 23	$24M	$66M	$89M
Q4 23	$24M	$68M	$92M
Q1 24	$22M	$57M	$80M
Q2 24	$37M	$32M	$69M
Q3 24	$22M	$39M	$61M
Q4 24	$17M	$34M	$51M
Q1 25	$19M	$23M	$42M
Q2 25	$18M	$13M	$31M
Q3 25	$19M	$22M	$41M
Q4 25	$20M	$18M	$38M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	42M	+0.8%	+32.9%
Q2 22	42M	+0.7%	+9.9%
Q3 22	43M	+0.1%	+20.4%
Q4 22	43M	+0.2%	+1.8%
Q1 23	43M	+0.5%	+1.5%
Q2 23	43M	+0.6%	+1.3%
Q3 23	43M	+0.0%	+1.3%
Q4 23	43M	+0.1%	+1.3%
Q1 24	43M	+0.2%	+1.0%
Q2 24	44M	+0.9%	+1.3%
Q3 24	44M	+0.1%	+1.4%
Q4 24	44M	+0.2%	+1.5%
Q1 25	44M	+0.5%	+1.7%
Q2 25	45M	+1.5%	+2.4%
Q3 25	45M	-0.3%	+2.0%
Q4 25	45M	+0.2%	+1.9%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	$20.6K	202
Q2 22	$19.1K	202
Q3 22	$23.5K	202
Q4 22	$24.7K	177
Q1 23	$28.4K	177
Q2 23	$28.3K	177
Q3 23	$34.7K	177
Q4 23	$32.8K	193
Q1 24	$29.1K	193
Q2 24	$34.3K	193
Q3 24	$39.4K	193
Q4 24	$50.4K	163
Q1 25	$44.2K	163
Q2 25	$44.6K	163
Q3 25	$48.1K	163
Q4 25	$66.0K	171

Revenue / Employee